These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2532510

  • 1. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population.
    Sundell IB, Nilsson TK, Hallmans G, Hellsten G, Dahlén GH.
    Atherosclerosis; 1989 Nov; 80(1):9-16. PubMed ID: 2532510
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO, Abdullah A, Tahzeeb S.
    Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
    [Abstract] [Full Text] [Related]

  • 3. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A, Bayraktar M, Kirazli S.
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [Abstract] [Full Text] [Related]

  • 4. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease.
    Smith FB, Lee AJ, Rumley A, Fowkes FG, Lowe GD.
    Atherosclerosis; 1995 May; 115(1):35-43. PubMed ID: 7669086
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjö, Sweden.
    Sundell IB, Nilsson TK, Rånby M, Hallmans G, Hellsten G.
    J Clin Epidemiol; 1989 May; 42(8):719-23. PubMed ID: 2503591
    [Abstract] [Full Text] [Related]

  • 6. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G.
    Circulation; 1998 Nov 24; 98(21):2241-7. PubMed ID: 9826309
    [Abstract] [Full Text] [Related]

  • 7. The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young women.
    Sundell IB, Nilsson TK, Hallmans G, Nygren C.
    Scand J Clin Lab Invest; 1988 Oct 24; 48(6):557-64. PubMed ID: 3146134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
    Glueck CJ, Glueck HI, Tracy T, Speirs J, Stroop D.
    Metabolism; 1993 Nov 24; 42(11):1410-9. PubMed ID: 8231835
    [Abstract] [Full Text] [Related]

  • 11. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ, Glueck HI, Stroop D, Speirs J, Hamer T, Tracy T.
    J Lab Clin Med; 1993 Oct 24; 122(4):412-20. PubMed ID: 8228555
    [Abstract] [Full Text] [Related]

  • 12. [The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects].
    Kobayashi Y, Fukuo Y, Shibuya T, Terashi A.
    Nihon Ronen Igakkai Zasshi; 1990 Sep 24; 27(5):578-83. PubMed ID: 2124638
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor.
    Crutchley DJ, McPhee GV, Terris MF, Canossa-Terris MA.
    Arteriosclerosis; 1989 Sep 24; 9(6):934-9. PubMed ID: 2511826
    [Abstract] [Full Text] [Related]

  • 15. Increased plasminogen activator inhibitor and tissue plasminogen activator levels in subjects with electrocardiographic abnormality indicative of ischaemic heart disease: a cross-sectional study in Norsjö, Sweden.
    Hellsten G, Boman K, Bjerle P, Blom P, Nilsson TK.
    Eur Heart J; 1992 Jan 24; 13(1):57-60. PubMed ID: 1577032
    [Abstract] [Full Text] [Related]

  • 16. Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass surgery in morbidly obese individuals.
    Sylvan A, Rutegård JN, Janunger KG, Sjölund B, Nilsson TK.
    Metabolism; 1992 Dec 24; 41(12):1370-2. PubMed ID: 1461144
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting fibrinolytic potential: cardiovascular fitness, body composition, and lipoprotein(a).
    Szymanski LM, Durstine JL, Davis PG, Dowda M, Pate RR.
    Metabolism; 1996 Nov 24; 45(11):1427-33. PubMed ID: 8931650
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: The Strong Heart Study.
    Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, Lee ET, Welty TK, Howard BV.
    Obes Res; 2000 Sep 24; 8(6):411-21. PubMed ID: 11011907
    [Abstract] [Full Text] [Related]

  • 20. Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study.
    Eliasson M, Røder ME, Dinesen B, Evrin PE, Lindahl B.
    Diabetes Care; 1997 Aug 24; 20(8):1252-5. PubMed ID: 9250449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.